The molecule, which the team named circRNA BRAKE—an acronym for Birc6-circRNA Repressing Adipogenesis and Krebs-cycle Energy—belongs to a class of genetic material called circular RNAs. Unlike the familiar linear messenger RNAs that carry protein-building instructions from DNA, circular RNAs are formed when a stretch of RNA loops back on itself and is joined end to end, creating a closed ring that is unusually stable and resistant to degradation. Most circular RNAs studied so far float in the cell’s cytoplasm or nucleus, where they act as sponges for other molecules or regulators of gene expression. What makes BRAKE remarkable is where it was found: inside mitochondria themselves, a location where RNA molecules of any kind are comparatively rare and poorly understood.

The researchers began by systematically profiling the circular RNAs present in mitochondria isolated from the white adipose tissue of obese male mice. White adipose tissue is the body’s main fat-storage depot, and its proper function depends on a delicate balance between the formation of new adipocytes—the process known as adipogenesis—and the metabolic activity of existing ones. When the team compared obese animals with lean controls, one circular RNA stood out: BRAKE was markedly upregulated in the mitochondria of obese mice’s fat tissue. That pattern suggested the molecule might be part of the cellular response to nutrient excess rather than an incidental byproduct.

To test whether BRAKE was merely a marker of obesity or an active participant in it, the researchers turned to loss-of-function experiments. When they specifically knocked down circRNA BRAKE in the adipocytes of male mice, the animals lost body weight, accumulated less fat, and showed improved insulin sensitivity. In other words, removing the brake allowed the metabolic machinery to shift in a direction that counteracted the consequences of obesity. Complementary in vitro studies reinforced the picture: in cell culture, circRNA BRAKE inhibited adipogenesis, the differentiation of precursor cells into mature fat cells.

The mechanistic heart of the study lies in how BRAKE exerts its influence. The team found that the circular RNA physically binds to ATP5A, a core component of ATP synthase—the molecular turbine embedded in the inner mitochondrial membrane that manufactures adenosine triphosphate, the universal energy currency of cells. By binding ATP5A, BRAKE disrupts the assembly of the ATP synthase complex. A partially assembled or destabilized ATP synthase works less efficiently, and the result is a measurable drop in ATP production within the cell.

That drop in ATP has consequences that ripple outward. Reduced cellular energy status dampens mTORC1 signaling, a master regulatory pathway that senses nutrient and energy availability and, when conditions are favorable, drives cell growth and differentiation. mTORC1 is well known to promote adipogenesis: when nutrients are abundant and ATP is plentiful, the pathway encourages precursor cells to commit to the fat-cell lineage. By throttling ATP synthesis and thereby weakening mTORC1 signaling, BRAKE effectively tells the tissue to hold back on manufacturing new fat cells even while the animal is in a state of nutrient overload. The molecule’s name—BRAKE—captures this function precisely.

This mechanism reframes how scientists think about mitochondrial dysfunction in obesity. Impaired adipogenesis is increasingly recognized as a contributor to obesity-associated metabolic disorders, and mitochondrial dysfunction has long been implicated in that impairment. But the idea that a mitochondria-localized circular RNA could tune the assembly of the electron transport chain’s flagship enzyme—and, through it, the entire adipogenic program—had not been demonstrated before. The study suggests that the mitochondrial genome’s neighborhood, and the RNA molecules that traffic within it, may be far more influential in systemic metabolism than previously appreciated.

Importantly, the findings are not confined to mice. The researchers examined omental white adipose tissue—the fat that wraps around the abdominal organs and is strongly linked to metabolic risk—obtained from patients with obesity. There, too, mitochondrial levels of circRNA BRAKE were elevated, and those levels were inversely correlated with the bioenergetic function of the patients’ mitochondria. In other words, the more BRAKE present in the mitochondria, the weaker the organelles’ energy-generating capacity. This human correlation lends clinical weight to the mouse experiments and suggests that the same molecular brake may operate in human fat tissue.

The therapeutic implications are tantalizing but must be handled with care. Because adipocyte-specific knockdown of BRAKE in mice reduced body weight and improved insulin sensitivity, one might imagine drugs that silence the circular RNA as a future treatment for obesity-related metabolic disease. Yet the biology cuts both ways: BRAKE appears to be a restraint mechanism, and its elevation in obesity may represent the body’s attempt to limit further fat expansion under nutrient stress. Interfering with such a brake could have complex, context-dependent effects, and the study’s authors frame circRNA BRAKE as a potential target rather than a validated drug destination. Delivering RNA-targeting therapeutics specifically to adipocyte mitochondria would also pose substantial technical challenges that remain unsolved.

What the study firmly establishes is a new principle: circular RNAs can reside inside mitochondria, bind core components of the oxidative phosphorylation machinery, and thereby regulate both cellular differentiation and whole-body metabolism. As sequencing technologies probe deeper into the mitochondrial RNA landscape, molecules like BRAKE may prove to be the first members of an entire regulatory class. For now, the image that lingers is a striking one—a ring-shaped RNA molecule, born from a gene called Birc6, threading its way into the cell’s power plants and gently jamming the gears of the ATP turbine, all in the service of keeping fat formation in check when the body is drowning in nutrients.

Subject of Research: A mitochondria-localized circular RNA that regulates adipogenesis and energy metabolism by disrupting ATP synthase assembly

Article Title: Mitochondria-localized circRNA BRAKE restrains adipogenesis under nutrient overload by disrupting ATP synthase assembly in mice

Article References: Mitochondria-localized circRNA BRAKE restrains adipogenesis under nutrient overload by disrupting ATP synthase assembly in mice. (n.d.). https://doi.org/10.1038/s41467-026-78378-z

Image Credits: AI Generated

DOI: 10.1038/s41467-026-78378-z

Keywords: circular RNA, mitochondria, adipogenesis, obesity, ATP synthase, mTORC1 signaling, white adipose tissue, insulin sensitivity, non-coding RNA, metabolic disease, ATP5A, energy metabolism

Mitochondria, the descendants of ancient bacteria that took up residence inside other cells more than a billion years ago, depend on a handful of large multiprotein assemblies to perform their essential duties. The mitochondrial electron transport chain, a series of respiratory complexes embedded in the inner membrane, shuttles electrons and pumps protons to generate the electrochemical gradient that drives the F1Fo-ATP synthase, the rotary molecular motor that manufactures most of the cell’s ATP. Alongside these energy-transducing machines sit the mitochondrial ribosome, or mitoribosome, which translates the handful of genes still encoded on the mitochondrial genome, and the Translocase of the Outer Membrane, or TOM complex, which imports the hundreds of proteins synthesized in the cytosol. In textbook animals and fungi, the compositions of these assemblies are well characterized and broadly similar. But over the past decade, studies of unicellular eukaryotes have exposed a startling degree of variation, with apicomplexan parasites emerging as particularly dramatic examples of divergence.

Apicomplexans, a group that includes the malaria parasites and Toxoplasma, have repeatedly remodeled their mitochondrial complexes, acquiring novel subunits that have no obvious counterparts in animals or plants. Some of these additions have been experimentally validated as essential for parasite growth, making them attractive candidates for drug development. What remained unresolved was whether these enlarged and divergent complexes were a recent innovation confined to the apicomplexan lineage, or whether they traced back to a deeper evolutionary origin. Answering that question required an organism positioned at a critical branching point in the eukaryotic tree of life, one close enough to apicomplexans to share their ancestry yet distinct enough to reveal which features are truly ancestral. Perkinsus marinus, a member of the Perkinsozoa, fits that role precisely.

The technique the researchers employed, complexome profiling, offers a powerful window into the native organization of protein assemblies within cells. Rather than analyzing proteins one by one after denaturing them, the method preserves intact complexes by gently solubilizing mitochondrial membranes, separates the assemblies according to their size under native conditions, and then slices the resulting separation profile into fractions. Each fraction is subjected to quantitative mass spectrometry, allowing every detected protein to be assigned a position along the size axis. Proteins that co-migrate in the same fractions across the profile are inferred to be components of the same complex, and shifts in migration relative to known markers can reveal changes in complex size or composition. Applied systematically, this approach produces a comprehensive map of the mitochondrial proteome organized by assembly, without requiring antibodies, genetic tags, or prior knowledge of each complex’s membership.

When Maclean, Iorillo, Faktorová, Singh, McGill, Lukeš and Sheiner applied this workflow to Perkinsus marinus, the results were striking. The parasite’s ATP synthase and electron transport chain complexes turned out to contain a suite of additional subunits previously identified only in apicomplexans. In Plasmodium and Toxoplasma, several of these components had already been shown through genetic studies to be important for parasite growth, underscoring their functional significance rather than mere decorative presence. Finding the same proteins assembled into the corresponding complexes in Perkinsus demonstrates that these subunits were present in the last common ancestor of the Myzozoa, the broader clade that unites apicomplexans, their closest relatives such as chromerid algae, the perkinsozoans, and the dinoflagellates. What had appeared to be a parasite-specific eccentricity is in fact a deeply conserved architectural plan.

Perhaps the most provocative discovery concerns the mitochondrial ribosome. Recent work on apicomplexans had revealed that their mitoribosomes carry a collection of divergent features, including associated proteins drawn from unexpected protein families. Among these are members of the ApiAP2 family, a group of proteins that, until those discoveries, had been considered exclusively as lineage-specific transcription factors regulating gene expression in the nucleus. The new complexome profile of Perkinsus shows that its mitoribosome possesses many of these same divergent characteristics, including ApiAP2 family members associated with the ribosomal assembly. The implication is remarkable: a protein family long defined by its role in DNA binding and transcriptional regulation has an ancestral, conserved second life inside the mitochondrial translation machinery of myzozoan organisms, a dual functionality that was invisible until proteomic methods capable of detecting native complexes were brought to bear.

The evolutionary logic of these findings carries weight beyond taxonomy. Myzozoans occupy a pivotal position in eukaryotic history, descending from photosynthetic ancestors through secondary endosymbiosis events and diversifying into lineages with radically different lifestyles, from free-living algae to obligate intracellular parasites. Establishing that the divergent mitochondrial complexes are shared across this breadth indicates that the remodeling occurred early, before the major myzozoan lineages split apart, and has since been maintained through hundreds of millions of years of evolution. Conservation on that scale suggests that the extra subunits are not evolutionary baggage but perform genuine, integrated roles, whether in stabilizing the complexes, regulating their activity, or mediating interactions unique to these organisms’ mitochondrial biology. For researchers studying mitochondrial evolution, Perkinsus now serves as a living fossil of sorts, preserving the ancestral myzozoan configuration of these molecular machines.

There are also practical consequences for human and animal health. Apicomplexan parasites impose an enormous burden on global health and agriculture, and the unusual subunits of their mitochondrial complexes have attracted attention precisely because they lack counterparts in their human or livestock hosts, offering the prospect of drugs that disable the parasite without harming the patient. A persistent concern in such efforts has been the possibility that each parasite lineage evolved its own idiosyncratic solutions, fragmenting the target space. The Perkinsus data counter that worry by showing that the divergent architecture is shared and conserved, which raises confidence that insights and inhibitors developed against one myzozoan mitochondrial complex may find relevance across the group. At the same time, the confirmation that essential growth factors in Plasmodium and Toxoplasma correspond to ancestral myzozoan components strengthens the case for these proteins as validated points of vulnerability.

Beyond the immediate findings, the study illustrates how much of eukaryotic molecular diversity remains hidden until the right lens is applied. Genome sequences alone could not have delivered these conclusions, because many of the divergent subunits are poorly conserved at the sequence level and their assignments to complexes depend on physical association rather than sequence similarity. Complexome profiling, by reading out the native assembly state of proteins, bridges that gap and can be deployed even in organisms that are genetically intractable, as many parasites and environmental protists are. As the method is extended across the tree of life, the picture emerging is one in which the mitochondrial complexes of model organisms represent only a narrow slice of a much richer evolutionary landscape. The oyster parasite, once studied chiefly as an economic threat to shellfish aquaculture, has now contributed a key piece to that broader map, anchoring the strange mitochondrial biology of malaria parasites to an ancient and enduring heritage shared across the Myzozoa.

Subject of Research: Mitochondrial complex composition in the myzozoan parasite Perkinsus marinus

Article Title: Complexome profiling of mitochondria in the myzozoan parasite of oysters, Perkinsus marinus

Article References: Maclean, A. E., Iorillo, O., Faktorová, D., Singh, M., McGill, S., Lukeš, J., & Sheiner, L. (2026). Complexome profiling of mitochondria in the myzozoan parasite of oysters, Perkinsus marinus. PLOS Pathogens, 22(9), e1014543. https://doi.org/10.1371/journal.ppat.1014543

Image Credits: AI Generated

DOI: 10.1371/journal.ppat.1014543

Keywords: Perkinsus marinus, mitochondria, complexome profiling, Myzozoa, apicomplexans, ATP synthase, electron transport chain, mitoribosome, ApiAP2, proteomics, PLOS Pathogens, parasite evolution

The technique itself has an interesting history. Polymethyl methacrylate, or PMMA, is the acrylic polymer familiar to orthopedic surgeons as bone cement, used for decades to fix prosthetic joints in place and to deliver local antibiotics to infected bone. In a surgical strategy originally developed for rebuilding large bone defects, a temporary PMMA spacer is implanted and later removed, and surgeons observed that a highly vascularized membrane forms around it. That membrane turned out to be far more than scar tissue: it secretes growth factors, supports the growth of blood vessels, and creates a regenerative environment that helps new bone form when the defect is finally grafted. The Chinese team reasoned that if the induced membrane is so good at orchestrating repair in bone, it might also explain why PMMA-based therapy appears to help diabetic foot ulcers, wounds that are notoriously stalled in a chronic, inflamed state.

To find out what is happening biologically, the researchers turned to transcriptomics, the systematic measurement of gene activity in tissue. They collected human diabetic foot ulcer tissue samples and performed ribonucleic acid sequencing, or RNA-seq, a technique that captures a snapshot of which genes are being transcribed into messenger RNA and at what intensity. Because tens of thousands of genes change in concert during wound healing, raw lists of differentially expressed genes can be overwhelming and hard to interpret. The team therefore layered on weighted gene co-expression network analysis, or WGCNA, a computational method that groups genes into modules based on how their expression patterns correlate across samples. Rather than asking which single genes differ between conditions, WGCNA asks which communities of genes rise and fall together, which often points more directly at the biological processes that matter.

The network analysis was striking in its scale and structure. The researchers identified eighteen distinct co-expression modules across the diabetic wound samples, and one of them, conventionally labeled the turquoise module, showed the strongest correlation with induced membrane formation. In other words, a coherent program of gene activity, involving hundreds of genes acting in concert, tracked with the presence and development of the membrane. When the team crossed the genes in this membrane-associated module with the differentially expressed genes identified across their experimental conditions, they arrived at a set of 422 overlapping genes that appear to sit at the intersection of membrane formation and the altered biology of the diabetic wound.

What those 422 genes do turned out to be unexpectedly fundamental. Functional enrichment analysis, a statistical method that tests whether a gene list is disproportionately packed with genes from particular biological pathways, revealed that the overlapping genes were concentrated in three interconnected processes: the citric acid cycle, respiratory electron transport, and the synthesis of adenosine triphosphate, or ATP, through chemiosmotic mechanisms. In plain terms, the induced membrane appears to be a metabolic powerhouse. ATP is the universal energy currency of cells, and the citric acid cycle and the electron transport chain, both housed in mitochondria, are the machinery that generates it efficiently through oxidative phosphorylation. Effective wound healing is an energy-hungry enterprise, demanding fuel for cell migration, proliferation, matrix deposition, and the construction of new blood vessels, so a membrane that revs up mitochondrial energy metabolism could plausibly help push a stalled chronic wound back into an active repair state.

Identifying that the membrane is metabolically active raised the next question: within a set of 422 genes, which are the critical regulatory nodes, the handful of molecules that truly matter? To answer this, the team deployed an ensemble of machine learning algorithms, a strategy increasingly common in genomics where the number of candidate genes vastly exceeds the number of samples. They applied Random Forest, an algorithm that builds many decision trees and ranks features by how useful they are for classification; least absolute shrinkage and selection operator regression, known as LASSO, which shrinks the coefficients of uninformative genes to zero and retains only the most predictive ones; and support vector machine-recursive feature elimination, or SVM-RFE, which iteratively discards the least informative features until the smallest discriminating set remains. Using all three methods in parallel and looking for consensus, the researchers narrowed the field to four candidate biomarker genes.

The four genes that survived this computational gauntlet were ATP5F1D, SNRPD2, RPL26, and NOC4L, and their identities tell a coherent story. ATP5F1D encodes the delta subunit of the F1 portion of ATP synthase, the remarkable rotary enzyme embedded in the inner mitochondrial membrane that manufactures ATP as protons flow down their electrochemical gradient. Its selection reinforces the enrichment findings, pointing squarely at mitochondrial energy metabolism as a central feature of the induced membrane’s biology. SNRPD2 is a component of the small nuclear ribonucleoprotein particles that form the spliceosome, the molecular machine that removes introns from pre-messenger RNA. RPL26 is a protein of the large subunit of the ribosome, the factory that translates messenger RNA into new proteins. NOC4L is associated with the nucleolus, the subnuclear compartment where ribosomes are assembled. Three of the four genes therefore converge on protein biosynthesis, from RNA splicing through ribosome construction to translation itself.

Taken together, the biomarker panel suggests that the induced membrane supports diabetic wound healing by sustaining two intertwined capacities: generating energy through mitochondrial respiration and building the proteins that cells need to proliferate, migrate, and lay down new tissue. This makes physiological sense for a regenerative microenvironment. Cells at a healing wound edge are among the most metabolically demanding in the body, and a local niche that supplies both abundant ATP and a high-capacity protein synthesis apparatus could help tip the balance from the chronic, hypoxic, inflammatory state that characterizes diabetic ulcers toward active repair. The authors are careful to frame their findings as hypothesis-generating, which is appropriate for a preliminary exploratory study, but the convergence of network analysis, pathway enrichment, and three independent machine learning approaches on a coherent metabolic and biosynthetic signature lends the hypothesis real weight.

The clinical implications are worth savoring. PMMA-induced membrane therapy is already in surgical use, and antibiotic-loaded cement is a familiar tool in the fight against diabetic foot infections, where local delivery of antibiotics can achieve high concentrations at the wound site while sparing the rest of the body systemic side effects. What this study adds is a mechanistic rationale: the cement is not merely a passive antibiotic reservoir and spacer, but an active inducer of a bioactive membrane whose gene expression profile resembles that of an energy-generating, protein-manufacturing regenerative tissue. If the four biomarker genes identified here can be validated in larger cohorts, they could serve as molecular indicators of whether a membrane is forming properly in a given patient, or even as targets for therapies designed to mimic or enhance the membrane’s effects without surgery.

There are, of course, important caveats. This was an exploratory transcriptomic study on human tissue samples, and gene expression correlations do not by themselves prove causation; the authors themselves emphasize that their work generates hypotheses about molecular mechanisms rather than confirming them. Diabetic foot ulcers are heterogeneous, shaped by vascular disease, neuropathy, infection, and glycemic control, and larger studies will be needed to confirm that the turquoise module and the four biomarker genes hold up across diverse patient populations. Still, the study is a compelling example of modern genomic science at work: taking a serendipitous surgical observation, subjecting it to RNA sequencing and network analysis, and extracting from thousands of genes a small, interpretable set of candidates centered on the most basic requirements of life in a healing wound. For the millions of patients whose diabetic foot ulcers stubbornly refuse to close, the humble bone cement may turn out to be doing something far more sophisticated than anyone realized, and the genes ATP5F1D, SNRPD2, RPL26, and NOC4L may become the signposts that guide the next generation of regenerative wound therapies.

Subject of Research: Transcriptomic mechanisms of PMMA-induced membrane therapy in diabetic foot ulcer healing

Article Title: Antibiotic-loaded PMMA bone cement promotes diabetic wound healing via induced membrane formation: a transcriptomic and mechanistic study

Article References: Zhu, W., Yin, X., Gui, W., Lin, X., Guo, R., & Li, L. (2026). Antibiotic-loaded PMMA bone cement promotes diabetic wound healing via induced membrane formation: a transcriptomic and mechanistic study. BMC Genomics. https://doi.org/10.1186/s12864-026-13318-1

Image Credits: AI Generated

DOI: 10.1186/s12864-026-13318-1

Keywords: diabetic foot ulcer, PMMA bone cement, induced membrane, RNA-seq, WGCNA, machine learning, mitochondrial energy metabolism, ATP synthase, protein biosynthesis, wound healing, transcriptomics, regenerative medicine

Researchers led by Ming Chen and Chenling Qu tracked two rice varieties—a japonica cultivar called Jinjingyou and an indica cultivar called C-liangyou Simiao—through 360 days of storage under three regimes. One group sat in conventional storage at 25 degrees Celsius and 65 percent relative humidity. A second group received 99 percent nitrogen for 40 days before re-aeration, a protocol designed to mirror the industry standard for rapid pest eradication. A third received 95 percent nitrogen for 180 days, matching the long-term pest suppression guideline from the Chinese standard LS/T 1225–2022. After the nitrogen phase, both treated groups were returned to ordinary air for the remainder of the year-long experiment.

The warning signs emerged at the end of storage. Freshness, measured by a bromothymol blue assay that tracks the acidic substances that accumulate as rice ages, fell significantly below conventional-storage levels in both nitrogen-treated groups by day 360. Germination rate, a proxy for the biological vigor of the embryo, dropped in parallel. The energy chemistry inside the kernels told the same story: ATP content and the cellular energy charge were significantly depleted in the re-aerated rice, while AMP accumulated, a signature of an energy-starved cell scrambling to stay functional.

To understand why, the team zeroed in on central carbon metabolism—the interconnected network of glycolysis, the tricarboxylic acid cycle, the mitochondrial electron transport chain, and the pentose phosphate pathway that converts stored starch into energy and building blocks. Even after harvest, rice kernels remain alive, burning through their own reserves to maintain basic physiology. The researchers measured the activities of seven key enzymes that gate the flow of carbon through this network, from hexokinase at the entry point of glycolysis to ATP synthase at the final step of mitochondrial energy production.

The enzyme data revealed a striking pattern of collapse. By day 360, mitochondrial isocitrate dehydrogenase, a rate-limiting enzyme of the TCA cycle, and ATP synthase, the core engine of oxidative phosphorylation, were both significantly suppressed in the re-aerated rice compared with conventional storage. The pentose phosphate pathway enzymes glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase were also significantly down, cutting the grain’s supply of NADPH, the reducing power that fuels antioxidant defense and nucleotide synthesis. Glycolytic enzymes showed dramatic fluctuations rather than the slow, stable decline seen in untreated rice, suggesting the treated grain was lurching through cycles of metabolic stress and partial recovery.

The most likely culprit, the authors suggest, is a phenomenon well known in plant physiology: the hypoxia–reoxygenation response. When plant tissues are deprived of oxygen and then suddenly re-exposed, reactive oxygen species surge, damaging mitochondrial membranes and inhibiting the very enzymes that generate cellular energy. The transient spike in isocitrate dehydrogenase and ATP synthase activity observed in the high-nitrogen group between days 40 and 180 fits this picture—a stress-repair response firing up when the air returned, followed by progressive exhaustion as the damage accumulated over the remaining months of storage.

Targeted metabolomics using UHPLC-MS/MS added molecular precision to the picture. Of 140 targeted metabolites, 95 passed quality filtering, and principal component and discriminant analyses cleanly separated the re-aerated rice from conventionally stored grain in both varieties. Five metabolites emerged as biomarkers of the accelerated decline. In the high-nitrogen group, fructose-6-phosphate, guanosine monophosphate, and AMP accumulated while cytosine was depleted—evidence of a traffic jam in glycolysis, disrupted nucleotide metabolism, and impaired capacity for DNA repair. In the low-nitrogen group, homogentisic acid, a precursor of the antioxidants tocopherol and plastoquinone, dropped sharply, signaling a weakened antioxidant shield.

The accumulation of fructose-6-phosphate is particularly telling. This glycolytic intermediate piled up in both varieties under the high-nitrogen protocol, likely because phosphofructokinase, the enzyme that should consume it downstream, was significantly inhibited. A stalled pipeline means less carbon flowing toward ATP production and fewer carbon skeletons for biosynthesis, a metabolic bottleneck that echoes findings in cold-stressed peas and nitrogen-starved apple roots, where fructose-6-phosphate likewise accumulates under duress.

The practical implications are immediate. Nitrogen treatment still does its job during the sealed phase—freshness was actually better preserved at day 180 in the long-nitrogen group than in conventional storage—but the benefits evaporate, and then reverse, once the grain meets ordinary air. The authors recommend that paddy rice be processed and consumed promptly after re-aeration rather than returned to long-term storage. They also point to possible remedies: gradual re-aeration to soften the oxidative burst, or exogenous metabolic regulators to restore carbon flux through the compromised pathways.

Caveats remain. The experiment was conducted under tightly controlled laboratory conditions of constant temperature and humidity, and the authors note that verification in real warehouses with full-scale nitrogen systems and longer storage horizons is still needed. Even so, the study reframes a technology often assumed to be purely protective. The nitrogen atmosphere, it turns out, does not simply pause the life of the grain—it reshapes its metabolism in ways that only become costly when the air comes back.

Subject of Research: Effects of nitrogen-modified atmosphere storage and re-aeration on central carbon metabolism and quality deterioration in stored paddy rice

Article Title: Nitrogen-modified atmosphere with re-aeration storage triggers deterioration in paddy rice by disrupting central carbon metabolism

Article References: Chen, M., Xue, F., Li, M., Liu, X., Zhang, Y., & Qu, C. (2026). Nitrogen-modified atmosphere with re-aeration storage triggers deterioration in paddy rice by disrupting central carbon metabolism. Food Chemistry: X, 39, Article 104524. https://doi.org/10.1016/j.fochx.2026.104524

Image Credits: AI Generated

DOI: 10.1016/j.fochx.2026.104524

Keywords: paddy rice, nitrogen-modified atmosphere storage, re-aeration, central carbon metabolism, glycolysis, TCA cycle, pentose phosphate pathway, ATP synthase, targeted metabolomics, grain storage quality, oxidative stress, seed germination